comparemela.com

Latest Breaking News On - Prnewswire innovent biologics inc - Page 1 : comparemela.com

Innovent Receives Fast Track Designation from the U.S. FDA for IBI343 (TOPO1i anti-CLDN18.2 ADC) as Monotherapy for Advanced Pancreatic Cancer

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology.

China
Rhui-zhou
Guangdong
Suzhou
Jiangsu
Adimab-incyte
Eli-lilly
Innovent-biologics
National-medical-products-administration
Prnewswire-innovent-biologics-inc
Linkedin
Md-anderson-cancer-center

Innovent to Present Multiple Clinical Study Results of Mazdutide at the ADA's 84th Scientific Sessions

/PRNewswire/ Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes.

United-states
Suzhou
Jiangsu
China
Peking
Beijing
American
Chinese
Adimab-incyte
Innovent-biologics
Eli-lilly
Linong-ji

Innovent Announces Data From Pivotal Phase 2 TRUST-I Study Of Taletrectinib(ROS1 Inhibitor) Are Published In The JCO And Reported At 2024 ASCO Annual ...

SAN FRANCISCO, U.S. and SUZHOU, China, June 1, 2024 /PRNewswire/ Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceut

Rhui-zhou
Guangdong
China
Tongji
Sichuan
Suzhou
Jiangsu
Shanghai
Hong-kong
Taiwan
Macau
United-states

Innovent Presents Phase 1 Clinical Data of First-in-class PD-1/IL-2α Bispecific Antibody Fusion Protein (IBI363) in Melanoma, Colorectal Cancer and other Solid Tumors at the 2024 ASCO Annual Meeting

/PRNewswire/ Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes.

China
Yu-chen
Zhejiang
Suzhou
Jiangsu
Fujian
Rhui-zhou
Guangdong
Australia
United-states
Innovent-biologics
Tingbo-liang

Innovent Presents at the 2024 ASCO Annual Meeting on Clinical Data of anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Pancreatic Cancer or Biliary Tract Cancer

/PRNewswire/ Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes.

China
Australia
Rhui-zhou
Guangdong
United-states
Suzhou
Jiangsu
American
Innovent-biologics
Hana-claudin
Eli-lilly
Xianjun-yu

vimarsana © 2020. All Rights Reserved.